Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Uncover various investment strategies designed to help you grow your wealth over time. Make informed investment decisions now.
6,430 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
A sharp upgrade, new AI partnerships, and a strategic move to Miami illuminate Palantir's potential. Learn how these ...
Crypto green! 6-9%! memes are driving momentum in today’s markets. This article breaks down the trend, profiles Pepe’...
Pediatrix (MD) 2025 earnings shaped a cautious optimism about growth and margins in a competitive pediatric care mark...
When a single stock surges on earnings guidance, it signals more than a momentary spike. This guide explains why band...
Two tech names, two very different stories. This guide breaks down Palantir and Microsoft to answer a simple question...
Discover two AI stocks that Wall Street analysts believe could move significantly higher. Learn what makes them stron...
Pediatrix Medical Group stock tumbled on Thursday after earnings highlighted modest revenue pressures and GAAP vs non...
Novo Nordisk isn’t in the spotlight, but its steady cash flow and strong pipeline could unlock long-term gains. This ...
Retirement is more than budgeting for groceries and utilities. This guide reveals three hidden costs retirees often m...
A week after Walmart’s investor day, the stock surged as analysts highlighted margin discipline and cash returns. Thi...
Starting with $1,000 can jumpstart a lasting investing habit. This guide shows practical ways to pick the best stocks...